DataMEDS AI Inc.
MEDS | NASDAQ
$2.00
+$0.08 (+4.17%)
Nov 2, 2026, 10:08 AM ET · Market open
Company Profile
DataMEDS AI is a Health IT company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units. The company incorporates its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contacts platform PharmacyChain™ to optimize the prescription medicines reimbursement and dispensing journey.
Key Executives
| Name | Position |
|---|---|
| Gerald E. Commissiong | Interim Co-Chief Executive Officer |
| Prashant Patel | Interim Co-CEO, President & Director |
| Brett Thompson | Chief Technology Officer |
| Eric Michael Sherb | Interim-CFO |
| Nikul Panchal | Senior Vice President of Pharmacy |
| Raj Mehta | SVP of Tech and Hub |
| Shafaat Pirani | Chief Clinical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 17, 2026 | 8-K | Current Report |
| Sep 16, 2026 | 8-K | Current Report |
| Aug 31, 2026 | PRE 14C | Filing |
| Aug 18, 2026 | 8-K | Current Report |
| Aug 17, 2026 | 10-Q | Quarterly Report |
| Aug 14, 2026 | 8-K | Current Report |
| Aug 14, 2026 | NT 10-Q | Filing |
| Aug 07, 2026 | S-1 | Filing |
| Aug 04, 2026 | 8-K | Current Report |
| Jul 21, 2026 | 8-K | Current Report |
DataMEDS AI Inc.
| Country | United States |
| IPO Date | Feb 21, 2025 |
| Industry | Medical - Distribution |
| Sector | Healthcare |
| Employees | 31 |
| CEO | Prashant Patel |
Contact Details
3000 Bayport Drive, Suite 950 Tampa,
Florida 33607 United States
Stock Details
| Ticker Symbol | MEDS |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0002030763 |
| CUSIP Number | 949503205 |
| ISIN Number | US9495032057 |
| SIC Code | 5122 |
Add to Watchlist
Select watchlists to add or remove MEDS